Navigation Links
APIC Launches 'Targeting Zero' Initiative to Eradicate C. Difficile and Infections Deemed Preventable By CMS
Date:12/18/2007

Campaign will Arm Infection Prevention Professionals With Guidelines and Tools

WASHINGTON, Dec. 18 /PRNewswire-USNewswire/ -- The Association for Professionals in Infection Control and Epidemiology (APIC) today announced a series of new educational initiatives aimed at eliminating healthcare-associated infections (HAIs), which include Clostridium difficile-associated disease and the three infections that the Centers for Medicare & Medicaid Services (CMS) have classified as preventable occurrences: catheter-associated urinary tract infections (UTIs), central line catheter-associated blood stream infections, and mediastinitis (a deep infection following coronary artery bypass surgery). The APIC programs will provide a comprehensive package of education, research and guidance for infection prevention and control professionals.

"As the nation's largest infection prevention organization, we are leading an effort to eradicate these infections," said Kathy L. Warye, Chief Executive Officer of APIC. "The Targeting Zero Campaign is intended to accelerate both learning and the delivery of practical tools for infection prevention professionals. In keeping with our efforts to create a culture of zero tolerance for non-compliance with measures proven to prevent HAIs, this program will clearly demonstrate to healthcare administrators and clinicians how they can implement effective strategies and simpler systems for protecting patients from these deadly infections."

Launching in January 2008, APIC's comprehensive program to address C. difficile will include a prevalence study to gain a better understanding of the scope of the problem. C. difficile is a bacterium that causes diarrhea and more serious intestinal conditions such as colitis. Over the past two years, a new strain of C. difficile has caused hospital outbreaks in several states.

APIC also intends to develop a Guide to the Elimination of C. difficile, including strategies for controlling transmission; an educational Webinar series, and a conference in the fall of 2008, featuring results of the prevalence study, along with the latest science, epidemiology and best practices in the elimination of C. difficile transmission.

To help infection prevention and control professionals address new changes to the CMS regulations which eliminate or reduce payments for three hospital-acquired infections, APIC will offer comprehensive educational programs on each of the three infections, using nationally recognized clinicians to discuss elimination strategies. APIC will also develop an elimination guide with practical implementation strategies for each infection.

"We want to prepare infection prevention and control professionals to more effectively educate and influence front-line healthcare teams about process improvements that could ensure safe patient outcomes," said Denise Murphy, president of APIC and Vice President of Safety and Quality, and Chief Patient Safety and Quality Officer at Barnes-Jewish Hospital at Washington University Medical Center in St. Louis. "Leveraging the new CMS Guidelines, we hope to heighten awareness among clinical and administrative leadership about the value of infection prevention. Responding to this challenge requires a blend of research, education and practice guidance -- a combination of activities that APIC is uniquely positioned to undertake. Following our positive experience taking a very comprehensive approach to MRSA in 2007, we plan to launch an aggressive fight against these deadly infections on multiple fronts in 2008."

For more information, please visit http://www.apic.org

APIC's mission is to improve health and patient safety by reducing risks of infection and other adverse outcomes. The Association's more than 11,000 members have primary responsibility for infection prevention, control and hospital epidemiology in healthcare settings around the globe. APIC advances its mission through education, research, collaboration, practice guidance, public policy, and credentialing. Visit APIC online at http://www.apic.org


'/>"/>
SOURCE Association for Professionals in Infection Control andEpidemiology
Copyright©2007 PR Newswire.
All rights reserved

Related medicine technology :

1. Iomai Launches Phase 1/2 Safety Study of Dose-Sparing Patch for Use With Pandemic Influenza Vaccine
2. Keeping the Data Center Clean: ATEN Launches Industry-First KVM Switches with Antimicrobial Nanocoating to Protect Products from Bacteria Surviving on Surfaces
3. Cell Therapeutics, Inc. (CTI) Launches Phase III Study for Pixantrone in Relapsed Indolent Non-Hodgkins Lymphoma (NHL)
4. Tengion Launches Second Phase 2 Clinical Trial of Regenerated Human Organ
5. Strategic Diagnostics Launches Initial Oncology-Targeted Antibody Reagent Catalog
6. deCODE Launches Phase II Clinical Testing of DG051 for the Prevention of Heart Attack
7. Premier Micronutrient Launches Supplement for Hearing Health
8. deCODE Launches deCODE MI(TM) -- A Test for a Major Genetic Risk Factor for Early-onset Heart Attack
9. PDHI Launches ConXus Rewards, Announces Partnership With Hallmark Insights to Support Incentive-Driven Wellness Programs
10. Seal Shield Launches Worlds First Antibacterial, Dishwasher Safe Keyboard and Mouse for Infection Control
11. PositiveFriends.com Launches STD Social Networking Site Balancing Dating with Online Support Features
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/27/2017)... Sept. 27, 2017  DarioHealth Corp. (NASDAQ: DRIO), a leading global digital ... its MyDario product is expected to appear on The Dr. Oz Show ... Oz Show airs in your area: http://www.doctoroz.com/page/where-watch-dr-oz-show ... The nine-time Emmy award-winning, The Dr. Oz Show kicked off ... The segment features ...
(Date:9/23/2017)... -- Janssen Biotech, Inc. (Janssen) announced today that it ... Food and Drug Administration (FDA) for the Biologics License ... of moderately to severely active rheumatoid arthritis (RA). The ... to further evaluate the safety of sirukumab in the ... "We are disappointed by ...
(Date:9/19/2017)... , Sept. 19, 2017 HistoSonics, Inc., a venture-backed medical device company developing a ... targeted tissues, announced three leadership team developments today:   ... ... ... Veteran medical device executive Josh Stopek , ...
Breaking Medicine Technology:
(Date:10/13/2017)... ... 2017 , ... Apple Rehab Shelton Lakes , which specializes in the ... facility as part of a disaster drill on October 3rd. , Apple Rehab participated ... Emergency Manager, as well as the Connecticut Long Term Care Mutual Aid Plan ...
(Date:10/13/2017)... ... 2017 , ... Global Healthcare Management’s 4th Annual Kids Fun Run brought out ... free event, sponsored by Global Healthcare Management’s CEO, Jon Letko, is aimed at getting ... children of all ages; it is a non-competitive, non-timed event, which is all about ...
(Date:10/13/2017)... ... October 13, 2017 , ... “The Journey: From the ... danger possible to save lost souls in the Philippines. “The Journey: From the Mountains ... a dedicated teacher of the Bible. She has taught all ages and currently teaches ...
(Date:10/12/2017)... ... 12, 2017 , ... Planet Fitness, one of the largest and fastest growing ... open a flagship location in Covington, LA at 401 N. U.S. Highway 190, in ... to Office Depot in the Holiday Square shopping center. Its location allows it to ...
(Date:10/12/2017)... ... October 12, 2017 , ... Asante, a nationally recognized ... have expanded their existing home health joint venture through an agreement, effective October ... a joint venture home health company with Asante, delivering clinically integrated care, for ...
Breaking Medicine News(10 mins):